Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia
Target Enrollment Completed Ahead of ScheduleTopline Data Expected Fourth Quarter 2020Results of Interim Analysis from the First 50 Percent of […]